United Therapeutics Quick Ratio 2006-2019 | UTHR

Historical quick ratio values for United Therapeutics (UTHR) over the last 10 years.
United Therapeutics Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2019-09-30 $1.84B $0.47B 3.91
2019-06-30 $2.04B $0.46B 4.41
2019-03-31 $1.85B $0.27B 6.84
2018-12-31 $1.67B $0.28B 6.03
2018-09-30 $1.51B $0.37B 4.05
2018-06-30 $1.52B $0.35B 4.35
2018-03-31 $1.53B $0.32B 4.81
2017-12-31 $1.34B $0.45B 3.01
2017-09-30 $1.53B $0.79B 1.93
2017-06-30 $1.45B $0.84B 1.73
2017-03-31 $1.40B $0.43B 3.27
2016-12-31 $1.33B $0.33B 3.98
2016-09-30 $1.29B $0.32B 4.11
2016-06-30 $1.23B $0.29B 4.19
2016-03-31 $1.21B $0.36B 3.39
2015-12-31 $1.19B $0.44B 2.71
2015-09-30 $1.15B $0.56B 2.06
2015-06-30 $0.75B $0.54B 1.39
2015-03-31 $0.92B $0.65B 1.43
2014-12-31 $0.89B $0.50B 1.77
2014-09-30 $1.02B $0.76B 1.33
2014-06-30 $0.82B $0.66B 1.25
2014-03-31 $0.94B $0.66B 1.43
2013-12-31 $0.87B $0.69B 1.26
2013-09-30 $0.88B $0.47B 1.88
2013-06-30 $0.86B $0.41B 2.08
2013-03-31 $0.81B $0.18B 4.56
2012-12-31 $0.63B $0.18B 3.57
2012-09-30 $0.67B $0.23B 2.95
2012-06-30 $0.52B $0.19B 2.79
2012-03-31 $0.53B $0.18B 3.01
2011-12-31 $0.52B $0.21B 2.43
2011-09-30 $0.80B $0.43B 1.88
2011-06-30 $0.84B $0.45B 1.84
2011-03-31 $0.77B $0.44B 1.75
2010-12-31 $0.73B $0.43B 1.70
2010-09-30 $0.57B $0.40B 1.42
2010-06-30 $0.49B $0.37B 1.33
2010-03-31 $0.37B $0.33B 1.13
2009-12-31 $0.30B $0.33B 0.90
2009-09-30 $0.30B $0.30B 0.99
2009-06-30 $0.27B $0.08B 3.56
2009-03-31 $0.25B $0.06B 4.22
2008-12-31 $0.28B $0.06B 4.91
2008-09-30 $0.28B $0.29B 0.96
2008-06-30 $0.27B $0.29B 0.91
2008-03-31 $0.32B $0.06B 5.20
2007-12-31 $0.34B $0.27B 1.24
2007-09-30 $0.28B $0.03B 8.38
2007-06-30 $0.23B $0.02B 10.04
2007-03-31 $0.21B $0.02B 10.75
2006-12-31 $0.27B $0.02B 13.78
2006-09-30 $0.17B $0.02B 8.42
2006-06-30 $0.20B $0.02B 8.23
2006-03-31 $0.18B $0.02B 9.95
2005-12-31 $0.16B $0.02B 10.71
2005-09-30 $0.14B $0.02B 7.98
2005-06-30 $0.12B $0.02B 7.42
2005-03-31 $0.11B $0.01B 9.24
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.572B $1.628B
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.471B 39.61
Takeda Pharmaceutical (TAK) Japan $60.597B 10.74
Astellas Pharma (ALPMY) Japan $32.582B 16.27
Eisai (ESALY) Japan $23.185B 44.70
Merck (MKGAF) Germany $17.215B 23.49
Grifols, S.A (GRFS) Spain $16.941B 22.20
Neurocrine Biosciences (NBIX) United States $9.626B 267.44
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $8.851B 36.42
Ionis Pharmaceuticals (IONS) United States $8.458B 17.13
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.968B 10.18
IPSEN SA ADR (IPSEY) France $6.104B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.540B 0.00
Hypermarcas (HYPMY) Brazil $5.461B 16.61
Evotec AG (EVTCY) Germany $4.261B 68.88
Arrowhead Pharmaceuticals (ARWR) United States $4.195B 77.87
Nektar Therapeutics (NKTR) United States $4.069B 0.00
FibroGen (FGEN) United States $3.977B 116.87
PTC Therapeutics (PTCT) United States $3.559B 0.00
Sage Therapeutics (SAGE) United States $3.528B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.790B 11.29
ChemoCentryx (CCXI) United States $2.786B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.092B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.086B 61.72
Xencor (XNCR) United States $2.070B 62.91
Ironwood Pharmaceuticals (IRWD) United States $1.891B 23.19
Heron Therapeutics (HRTX) United States $1.891B 0.00
Tilray (TLRY) Canada $1.748B 0.00
USANA Health Sciences (USNA) United States $1.626B 17.00
Corcept Therapeutics (CORT) United States $1.525B 18.53
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.469B 10.02
Zogenix (ZGNX) United States $1.424B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.424B 0.00
Endo (ENDP) Ireland $1.395B 2.56
Portola Pharmaceuticals (PTLA) United States $1.062B 0.00
Akebia Therapeutics (AKBA) United States $1.041B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.034B 32.03
Dermira (DERM) United States $1.022B 0.00
ImmunoGen (IMGN) United States $1.018B 0.00
Karyopharm Therapeutics (KPTI) United States $0.966B 0.00
Radius Health (RDUS) United States $0.922B 0.00
Aerie Pharmaceuticals (AERI) United States $0.901B 0.00
Collegium Pharmaceutical (COLL) United States $0.775B 0.00
TherapeuticsMD (TXMD) United States $0.673B 0.00
Flexion Therapeutics (FLXN) United States $0.631B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.543B 0.00
Molecular Templates (MTEM) United States $0.536B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.492B 59.63
BioSpecifics Technologies Corp (BSTC) United States $0.478B 20.59
Ardelyx (ARDX) United States $0.474B 0.00
Translate Bio (TBIO) United States $0.471B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.444B 0.00
Innate Pharma SA (IPHYF) France $0.442B 0.00
Organogenesis Holdings (ORGO) United States $0.431B 0.00
Recro Pharma (REPH) United States $0.420B 0.00
Indivior (INVVY) United States $0.417B 2.48
BioCryst Pharmaceuticals (BCRX) United States $0.415B 0.00
Siga Technologies (SIGA) United States $0.393B 8.98
DURECT (DRRX) United States $0.377B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.372B 0.00
Harpoon Therapeutics (HARP) United States $0.370B 0.00
Lannett Co Inc (LCI) United States $0.367B 5.91
Calithera Biosciences (CALA) United States $0.366B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.356B 0.00
Rafael Holdings (RFL) United States $0.349B 0.00
Concert Pharmaceuticals (CNCE) United States $0.322B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.320B 0.00
OptiNose (OPTN) United States $0.285B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.272B 0.00
KalVista Pharmaceuticals (KALV) United States $0.270B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.267B 0.00
Ocular Therapeutix (OCUL) United States $0.250B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.228B 0.00
MEI Pharma (MEIP) United States $0.227B 0.00
IMV INC (IMV) Canada $0.213B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.205B 0.00
Nature's Sunshine Products (NATR) United States $0.205B 35.27
Taiwan Liposome (TLC) Taiwan $0.200B 0.00
Jounce Therapeutics (JNCE) United States $0.194B 2.60
AcelRx Pharmaceuticals (ACRX) United States $0.127B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.125B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.124B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
Otonomy (OTIC) United States $0.114B 0.00
Aquestive Therapeutics (AQST) United States $0.110B 0.00
Redhill Biopharma (RDHL) Israel $0.110B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.108B 0.00
Xeris Pharmaceuticals (XERS) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.097B 0.00
CV Sciences (CVSI) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.084B 0.00
MediWound (MDWD) Israel $0.081B 0.00
Neos Therapeutics (NEOS) United States $0.078B 0.00
Infinity Pharmaceuticals (INFI) United States $0.078B 0.00
Onconova Therapeutics (ONTX) United States $0.074B 0.00
CTI BioPharma (CTIC) United States $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.070B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.068B 20.23
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
Aclaris Therapeutics (ACRS) United States $0.056B 0.00
Nivalis Therapeutics (ALPN) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00
VAXART, INC (VXRT) United States $0.052B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.052B 0.00
Natural Alternatives (NAII) United States $0.052B 23.44
Dipexium Pharmaceuticals (PLXP) United States $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
PolarityTE (PTE) United States $0.046B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Jaguar Animal Health (JAGX) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Biomerica (BMRA) United States $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
Cardiome Pharma (CORV) Canada $0.017B 0.00
Shineco (TYHT) China $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Novan (NOVN) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Vical (BBI) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00